Plans Could Face Limits on Pharmacy Steering

Summary#

HB 1390, titled “Health insurance; pharmacies, freedom of choice, delivery of prescription drugs, penalties,” would amend and reenact three sections of the Virginia Code. Its title points to a goal of protecting pharmacy choice and changing rules about prescription delivery; the text does not give a separate goal statement.

  • Insurers, health plans, health maintenance organizations (HMOs) and their pharmacy benefit managers would have to let covered people choose a pharmacy or other listed clinical setting, including one outside the plan’s network, subject to the bill’s conditions.
  • A non-network pharmacy seeking these protections would have to agree to accept the same reimbursement rates and copayment terms that apply to network pharmacies, as payment in full. The insurer or plan would have to verify those terms promptly.
  • Plans could not use unequal copayments or fees, certain monetary penalties, reduced reimbursement, or policies requiring or encouraging prescriptions to be sent to specified destinations to influence pharmacy choice.
  • A pharmacy would have 30 days to sign a required provider agreement after a written request or would not receive the bill’s protections until it did. Plans would have to act on a pharmacy’s agreement request within 60 days, but the bill does not require approval.
  • The bill preserves a single exclusive mail-order pharmacy option. It also excludes certain HMO benefits obtained from a pharmacy wholly owned and operated by, or exclusively operated for, the HMO.
  • The bill would bar retaliation against pharmacies or dispensing practitioners for exercising rights or providing services consistent with these rules. The supplied status says the bill is introduced and continued from last session; it is not law.

What it means for you#

  • People with covered pharmacy benefits: You would have a right to choose among pharmacies and listed clinical settings, including some non-network providers. If a non-network pharmacy has agreed to the required payment terms, you would not owe more than the plan’s reimbursement plus the applicable copayment.
  • Pharmacies and dispensing practitioners: A pharmacy seeking the bill’s protections may have to sign the same provider agreement required of network pharmacies. The bill would require prompt transmission and verification of reimbursement terms, and action on agreement requests within 60 days. It would not require plans to contract with a pharmacy’s intermediary or share confidential information with it.
  • Insurers, plans, HMOs and pharmacy benefit managers: They would have to follow the choice and equal-treatment rules and could not retaliate against providers for complying. The bill does not create a new office or specify a new enforcement process.
  • People using mail-order services or HMO-owned pharmacies: The bill preserves the single mail-order pharmacy exception. Its choice rules would not apply to the specified HMO-owned or exclusively operated pharmacy benefits.

Money#

No publicly available information on costs is in the supplied materials.

  • The bill sets no public spending amount, fee, fine, or payment to pharmacies.
  • It would affect reimbursement terms and limit what a covered person may owe when using a qualifying non-network pharmacy. The materials do not estimate the financial effect.
  • The bill requires plans to handle reimbursement notices promptly and act on agreement requests within 60 days, but gives no staffing or compliance cost estimate.

What is unclear#

  • The current versions of the three amended sections were not supplied, so it is not possible to verify which protections are already law and which would be new.
  • The bill does not set out how complaints or alleged violations would be handled. It says the State Corporation Commission has no jurisdiction to decide disputes under these sections, but does not identify another process.
  • The text does not define how to determine whether a practice “incentiviz[es]” sending a prescription to a specified destination.
  • It is unclear how the delivery restrictions interact with the mail-order exception in particular cases.
  • The title refers to penalties, but the supplied text does not set out fines or other penalties for violations.

Case for#

  • A possible argument for the bill is that it would give people more choice about where to obtain pharmacy benefits, including specialty drugs.
  • Requiring equal copayments and limiting extra charges could protect people from paying more simply because they use a qualifying non-network pharmacy.
  • Prompt verification of reimbursement terms could make it easier for pharmacies and patients to know what the plan will pay.
  • The anti-retaliation rule could help providers exercise the bill’s protections without fear of being penalized for doing so.

Case against#

  • One concern is that the bill restricts plans’ ability to encourage people to use particular pharmacies or delivery arrangements, while its exceptions leave some arrangements outside the choice rules.
  • The bill creates rights and duties but does not identify a dispute process or enforcement body; the Commission is expressly excluded from deciding these disputes.
  • A pharmacy that does not sign a requested provider agreement within 30 days would lose the bill’s protections for that plan until it signs, which could limit the practical value of the choice right.
  • Because the current law was not supplied, it is unclear how much of the bill would change existing protections.